Polymorphisms of the CYP1A1 gene have been associated with increased aryl hydrocarbon hydroxylase activity which in turn may change individual’s susceptibility to breast cancer by either increasing risk in women in different parts of the world (10–14), or had no effect on the disease outcome (15–17). Here, CYP1A1 is linked to breast cancer.